Effect of Pressurized Intraperitoneal Aerosol Chemotherapy on the Survival Rate of Patients with Peritoneal Carcinomatosis of Gastric Origin

ConclusionThe overall survival at 6  months after the diagnosis of carcinomatosis was significantly better for PIPAC_CHEM patients. This difference appears to continue until at least 18 months. At 6 months, days of additional hospitalization was significantly less in the PIPAC_CHEM group.Trial RegistrationClinicaltrials.gov Identifier: NCT 04,879,953
Source: Journal of Gastrointestinal Cancer - Category: Cancer & Oncology Source Type: research